PIRS - Pieris Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $108.83. This is a potential upside of $96.8 (804.66%) from yesterday's end of day stock price of $12.03.

Pieris Pharmaceuticals's activity chart (see below) currently has 3 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 302 days.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 12-Mar-2020. First documented stock forecast 05-Aug-2016.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5 years 3 months 1 days ago
(12-Mar-2020)

2/3 (66.67%)

$96.8 (31.93%)

302

Show more analysts

What is PIRS (Pieris Pharmaceuticals) average time for price targets to be met?

On average it took 302 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on PIRS (Pieris Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on PIRS (Pieris Pharmaceuticals)?

Joseph Pantginis has 32 price targets and 28 ratings on PIRS

Which analyst is the currently most bullish on PIRS (Pieris Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $0